Jia, N. & Patel, D. J. Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins. Nat. Rev. Mol. Cell Biol. 22, 563–579 (2021).
Article CAS PubMed Google Scholar
Borges, A. L., Davidson, A. R. & Bondy-Denomy, J. The discovery, mechanisms, and evolutionary impact of anti-CRISPRs. Annu. Rev. Virol. 4, 37–59 (2017).
Article CAS PubMed PubMed Central Google Scholar
Davidson, A. R. et al. Anti-CRISPRs: protein inhibitors of CRISPR–Cas systems. Annu. Rev. Biochem. 89, 309–332 (2020).
Article CAS PubMed PubMed Central Google Scholar
Li, Y. & Bondy-Denomy, J. Anti-CRISPRs go viral: the infection biology of CRISPR–Cas inhibitors. Cell Host Microbe 29, 704–714 (2021).
Pawluk, A., Davidson, A. R. & Maxwell, K. L. Anti-CRISPR: discovery, mechanism and function. Nat. Rev. Microbiol. 16, 12–17 (2018).
Article CAS PubMed Google Scholar
Shivram, H., Cress, B. F., Knott, G. J. & Doudna, J. A. Controlling and enhancing CRISPR systems. Nat. Chem. Biol. 17, 10–19 (2021).
Article CAS PubMed Google Scholar
Sontheimer, E. J. & Davidson, A. R. Inhibition of CRISPR–Cas systems by mobile genetic elements. Curr. Opin. Microbiol. 37, 120–127 (2017).
Article CAS PubMed PubMed Central Google Scholar
Stanley, S. Y. & Maxwell, K. L. Phage-encoded anti-CRISPR defenses. Annu. Rev. Genet. 52, 445–464 (2018).
Article CAS PubMed Google Scholar
Trasanidou, D. et al. Keeping CRISPR in check: diverse mechanisms of phage-encoded anti-CRISPRs. FEMS Microbiol. Lett. 366, fnz098 (2019).
Wiegand, T., Karambelkar, S., Bondy-Denomy, J. & Wiedenheft, B. Structures and strategies of anti-CRISPR-mediated immune suppression. Annu. Rev. Microbiol. 74, 21–37 (2020).
Article CAS PubMed PubMed Central Google Scholar
Marino, N. D., Pinilla-Redondo, R., Csorgo, B. & Bondy-Denomy, J. Anti-CRISPR protein applications: natural brakes for CRISPR–Cas technologies. Nat. Methods 17, 471–479 (2020).
Article CAS PubMed PubMed Central Google Scholar
van der Oost, J., Westra, E. R., Jackson, R. N. & Wiedenheft, B. Unravelling the structural and mechanistic basis of CRISPR–Cas systems. Nat. Rev. Microbiol. 12, 479–492 (2014).
Article PubMed PubMed Central Google Scholar
Jackson, R. N., van Erp, P. B., Sternberg, S. H. & Wiedenheft, B. Conformational regulation of CRISPR-associated nucleases. Curr. Opin. Microbiol. 37, 110–119 (2017).
Article CAS PubMed PubMed Central Google Scholar
Nishimasu, H. & Nureki, O. Structures and mechanisms of CRISPR RNA-guided effector nucleases. Curr. Opin. Struct. Biol. 43, 68–78 (2017).
Article CAS PubMed Google Scholar
Molina, R., Sofos, N. & Montoya, G. Structural basis of CRISPR–Cas type III prokaryotic defence systems. Curr. Opin. Struct. Biol. 65, 119–129 (2020).
Article CAS PubMed Google Scholar
Nussenzweig, P. M. & Marraffini, L. A. Molecular mechanisms of CRISPR–Cas immunity in bacteria. Annu. Rev. Genet. 54, 93–120 (2020).
Article CAS PubMed Google Scholar
Koonin, E. V. & Makarova, K. S. Evolutionary plasticity and functional versatility of CRISPR systems. PLoS Biol. 20, e3001481 (2022).
Article CAS PubMed PubMed Central Google Scholar
McGinn, J. & Marraffini, L. A. Molecular mechanisms of CRISPR–Cas spacer acquisition. Nat. Rev. Microbiol. 17, 7–12 (2019).
Article CAS PubMed Google Scholar
Koonin, E. V., Makarova, K. S. & Zhang, F. Diversity, classification and evolution of CRISPR–Cas systems. Curr. Opin. Microbiol. 37, 67–78 (2017).
Article CAS PubMed PubMed Central Google Scholar
Amitai, G. & Sorek, R. CRISPR–Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67–76 (2016).
Article CAS PubMed Google Scholar
Mosterd, C., Rousseau, G. M. & Moineau, S. A short overview of the CRISPR–Cas adaptation stage. Can. J. Microbiol. 67, 1–12 (2021).
Article CAS PubMed Google Scholar
Sasnauskas, G. & Siksnys, V. CRISPR adaptation from a structural perspective. Curr. Opin. Struct. Biol. 65, 17–25 (2020).
Hochstrasser, M. L. & Doudna, J. A. Cutting it close: CRISPR-associated endoribonuclease structure and function. Trends Biochem. Sci. 40, 58–66 (2015).
Article CAS PubMed Google Scholar
Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602–607 (2011).
Article CAS PubMed PubMed Central Google Scholar
Brouns, S. J. et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960–964 (2008).
Article CAS PubMed PubMed Central Google Scholar
Wiedenheft, B., Sternberg, S. H. & Doudna, J. A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482, 331–338 (2012).
Article CAS PubMed Google Scholar
Marraffini, L. A. & Sontheimer, E. J. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11, 181–190 (2010).
Article CAS PubMed PubMed Central Google Scholar
Garneau, J. E. et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 (2010).
Article CAS PubMed Google Scholar
Makarova, K. S. et al. Evolution and classification of the CRISPR–Cas systems. Nat. Rev. Microbiol. 9, 467–477 (2011).
Article CAS PubMed Google Scholar
Makarova, K. S., Zhang, F. & Koonin, E. V. SnapShot: class 1 CRISPR–Cas systems. Cell 168, 946 (2017).
Article CAS PubMed Google Scholar
Makarova, K. S., Zhang, F. & Koonin, E. V. SnapShot: class 2 CRISPR–Cas systems. Cell 168, 328 (2017).
Article CAS PubMed Google Scholar
Shmakov, S. et al. Diversity and evolution of class 2 CRISPR–Cas systems. Nat. Rev. Microbiol. 15, 169–182 (2017).
Article CAS PubMed PubMed Central Google Scholar
Smargon, A. A. et al. Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell 65, 618–630 (2017).
Article CAS PubMed PubMed Central Google Scholar
Konermann, S. et al. Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173, 665–676 (2018).
Article CAS PubMed PubMed Central Google Scholar
Meeske, A. J., Nakandakari-Higa, S. & Marraffini, L. A. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage. Nature 570, 241–245 (2019). The paper demonstrates that the trans-RNase activity of Cas13 arrests host growth, thereby interrupting the infectious cycle.
Article CAS PubMed PubMed Central Google Scholar
Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016). This article characterizes Cas13 (known as C2c2) for the first time and shows that Cas13a can be programmed for RNA interference in E. coli cells.
Article PubMed PubMed Central Google Scholar
van Beljouw, S. P. B., Sanders, J., Rodriguez-Molina, A. & Brouns, S. J. J. RNA-targeting CRISPR–Cas systems. Nat. Rev. Microbiol. 21, 21–34 (2023).
Yan, W. X. et al. Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol. Cell 70, 327–339 (2018).
留言 (0)